Recent Updates
Recently added Catalysts
RADX Positive Sentiment Score: 60/100

Lantheus Strategic Investment and Capital Raise Presentation

Tuesday, June 25, 2024 1 min read
Key Takeaway: Radiopharm Theranostics has announced the dosing of its first patient in a Phase 1/2a clinical study of BetaBart (RV-01). The company has also received IND approval from the US FDA to initiate a therapeutic clinical study targeting B7H3. Additionally, positive updates have been provided across four of its clinical programs.

Market Sentiment Analysis

POSITIVE FACTORS

  • Radiopharm Theranostics has initiated a Phase 1/2a clinical study.
  • The company received IND approval from the US FDA.
  • Positive clinical updates have been shared across four programs.

Full Press Release Details

• Announcements
• June 25, 2024
Loading Viewer…

More Announcements & Updates

• Announcements
• December 22, 2023
• Announcements
• January 11, 2022
• Announcements
• January 10, 2025
• Announcements
• December 19, 2024

Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)

Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

• RAD Presentation June 2026
• Zacks Small-Cap Research 2026
• RAD Presentation March 2026
• Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
• Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
• Zacks Small-Cap Research

Frequently Asked Questions

What is the BetaBart (RV-01) study about?

The BetaBart (RV-01) study is a Phase 1/2a clinical trial initiated by Radiopharm Theranostics.

What recent approval did Radiopharm receive?

Radiopharm Theranostics received IND approval from the US FDA to start its therapeutic clinical study.

What updates have been shared by Radiopharm?

Radiopharm has provided positive clinical updates across four of its programs.

Tags: RADX Viatris Investor Conferences Healthcare Radiopharm Theranostics BetaBart Phase 1/2a FDA IND approval clinical study
Last updated: Jun 25, 2024